中国免疫学杂志
中國免疫學雜誌
중국면역학잡지
CHINESE JOURNAL OF IMMUNOLOGY
2010年
3期
254-257
,共4页
李丽娜%王华%周蕾%张永胜%于永利%王丽颖%孙陆果
李麗娜%王華%週蕾%張永勝%于永利%王麗穎%孫陸果
리려나%왕화%주뢰%장영성%우영리%왕려영%손륙과
ICR小鼠%博莱霉素%肺间质纤维化
ICR小鼠%博萊黴素%肺間質纖維化
ICR소서%박래매소%폐간질섬유화
ICR mouse%Bleomycin%Pulmonary fibrosis
目的:建立博莱霉素导致肺间质纤维化小鼠动物模型,比较不同给药方式的成模差异.方法:利用8周龄雄性ICR小鼠,①随机分为腹腔给药组(P 组)、气管内给药组(I组)、阴性对照组(C组),分别经腹腔注射BLM 40 mg/kg 5次、气管内滴入BLM 5 mg/kg 1次或气管内滴入生理盐水50 μl.分别于14、28、40天处死,②小鼠随机分为4组,分别经腹腔注射BLM 40 mg/kg~3、4、5次或经腹腔给予生理盐水200 μl.分别于28、40天处死.观察小鼠体重、咳嗽、挠鼻症状、肺系数及肺组织病理改变.结果:给予博莱霉素后①小鼠的体重均下降并出现咳嗽及挠鼻等呼吸障碍症状;处置后第14、28及40天处死小鼠,计算肺系数,P组较I组肺系数高;处死小鼠后,P组和I组小鼠均形成广泛、稳定的间质纤维化病理改变,P组主要分布在胸膜下及血管周围,而I组主要分布在肺门和支气管周围.P组较I组肺纤维化病理评分高.②不同腹腔给药次数模型小鼠体重变化以5次给药对体重影响最大;计算肺系数以给药5次肺系数变化最大.上述模型均成功建立.通过比较生存率、呼吸困难症状、组织病理变化等指标,选出腹腔给药5次相对于给药3次及4次为更好的造模方式.结论:利用BLM腹腔注射和气管内滴入制备了肺间质纤维化动物模型,纤维化形成的部位存在着一定的差异,腹腔给药5次方法制备肺间质纤维化模型的成功率更佳.
目的:建立博萊黴素導緻肺間質纖維化小鼠動物模型,比較不同給藥方式的成模差異.方法:利用8週齡雄性ICR小鼠,①隨機分為腹腔給藥組(P 組)、氣管內給藥組(I組)、陰性對照組(C組),分彆經腹腔註射BLM 40 mg/kg 5次、氣管內滴入BLM 5 mg/kg 1次或氣管內滴入生理鹽水50 μl.分彆于14、28、40天處死,②小鼠隨機分為4組,分彆經腹腔註射BLM 40 mg/kg~3、4、5次或經腹腔給予生理鹽水200 μl.分彆于28、40天處死.觀察小鼠體重、咳嗽、撓鼻癥狀、肺繫數及肺組織病理改變.結果:給予博萊黴素後①小鼠的體重均下降併齣現咳嗽及撓鼻等呼吸障礙癥狀;處置後第14、28及40天處死小鼠,計算肺繫數,P組較I組肺繫數高;處死小鼠後,P組和I組小鼠均形成廣汎、穩定的間質纖維化病理改變,P組主要分佈在胸膜下及血管週圍,而I組主要分佈在肺門和支氣管週圍.P組較I組肺纖維化病理評分高.②不同腹腔給藥次數模型小鼠體重變化以5次給藥對體重影響最大;計算肺繫數以給藥5次肺繫數變化最大.上述模型均成功建立.通過比較生存率、呼吸睏難癥狀、組織病理變化等指標,選齣腹腔給藥5次相對于給藥3次及4次為更好的造模方式.結論:利用BLM腹腔註射和氣管內滴入製備瞭肺間質纖維化動物模型,纖維化形成的部位存在著一定的差異,腹腔給藥5次方法製備肺間質纖維化模型的成功率更佳.
목적:건립박래매소도치폐간질섬유화소서동물모형,비교불동급약방식적성모차이.방법:이용8주령웅성ICR소서,①수궤분위복강급약조(P 조)、기관내급약조(I조)、음성대조조(C조),분별경복강주사BLM 40 mg/kg 5차、기관내적입BLM 5 mg/kg 1차혹기관내적입생리염수50 μl.분별우14、28、40천처사,②소서수궤분위4조,분별경복강주사BLM 40 mg/kg~3、4、5차혹경복강급여생리염수200 μl.분별우28、40천처사.관찰소서체중、해수、뇨비증상、폐계수급폐조직병리개변.결과:급여박래매소후①소서적체중균하강병출현해수급뇨비등호흡장애증상;처치후제14、28급40천처사소서,계산폐계수,P조교I조폐계수고;처사소서후,P조화I조소서균형성엄범、은정적간질섬유화병리개변,P조주요분포재흉막하급혈관주위,이I조주요분포재폐문화지기관주위.P조교I조폐섬유화병리평분고.②불동복강급약차수모형소서체중변화이5차급약대체중영향최대;계산폐계수이급약5차폐계수변화최대.상술모형균성공건립.통과비교생존솔、호흡곤난증상、조직병리변화등지표,선출복강급약5차상대우급약3차급4차위경호적조모방식.결론:이용BLM복강주사화기관내적입제비료폐간질섬유화동물모형,섬유화형성적부위존재착일정적차이,복강급약5차방법제비폐간질섬유화모형적성공솔경가.
Objective:To study the differences of bleomycin-induced pulmonary fibrosis in mice induced by intraperitoneal injection and intratracheal instillation of bleomycin.Methods:ICR mice (male,8 w of age,18 to 22 g bodyweight) were used.①ICR mice were randomly divided into three groups.In the group P,bleomycin was injected intraperitoneal five times in a dose of 40 mg/kg,and in the group I,bleomycin was instilled intratracheally in a dose of 5 mg/kg.The mice were killed at 14,28 or 40 day.②ICR mice were randomly divided into four groups : bleomycin was injected intraperitoneal three,four or five times in a dose of 40 mg/kg,and in the group control ,bleomycin was injected intraperitoneal in a dose of 200 μl for five times.The mice was killed at 28 or 40 day.The pathological changes and symptoms were observed.Results:① The weight of the mice given blemycine were lost after injection.Symptoms were more serious in group P than those of group I.The pulmonary coefficient of group P was more than that of group I.At 28 day after injection,fibrosis was widely and stably formed mainly in around the bronchia and bronchioles,especially,near the pulmonary hilar area,in the group I mice,however,the same changes were mainly seen under the pleura or perivascular pulmonary tissues in the mice of group P.The pathological score of pulmonary fibrosis was different between those two groups.②Different dose of bleomycine induced different change of the mouse's weight.The most of all of the three group were five time injection; The lung index of five time injection of bleomycine was the most.The pulmonary fibrosis mouse model was made successfully.After comparising all of the data,we found intraperitoneal of bleomycine five times was the more convenient method.Conclusion:The sites of pulmonary fibrosis in the mice are different between the mice induced by intraperitoneal injection or intratracheal instillation of bleomycin.Intraperitoneal injection five times is a more convenient method to make pulmonary fibrosis.